BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21387295)

  • 1. Efficacy and safety of liver transplantation in patients with cholangiocarcinoma: a systematic review and meta-analysis.
    Gu J; Bai J; Shi X; Zhou J; Qiu Y; Wu Y; Jiang C; Sun X; Xu F; Zhang Y; Ding Y
    Int J Cancer; 2012 May; 130(9):2155-63. PubMed ID: 21387295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Meta-analysis of efficacy and safety of liver transplantation in treating cholangiocarcinoma].
    Gu JY; Bai JL; Shi XL; Zhou JX; Qiu YD; Wu YF; Jiang CP; Sun XT; Xu FG; Zhang Y; Ding YT
    Zhonghua Wai Ke Za Zhi; 2011 Apr; 49(4):351-6. PubMed ID: 21612703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience.
    Duignan S; Maguire D; Ravichand CS; Geoghegan J; Hoti E; Fennelly D; Armstrong J; Rock K; Mohan H; Traynor O
    HPB (Oxford); 2014 Jan; 16(1):91-8. PubMed ID: 23600750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
    Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
    Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma.
    Mantel HT; Rosen CB; Heimbach JK; Nyberg SL; Ishitani MB; Andrews JC; McKusick MA; Haddock MG; Alberts SR; Gores GJ
    Liver Transpl; 2007 Oct; 13(10):1372-81. PubMed ID: 17427173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma.
    Panjala C; Nguyen JH; Al-Hajjaj AN; Rosser BA; Nakhleh RE; Bridges MD; Ko SJ; Buskirk SJ; Kim GP; Harnois DM
    Liver Transpl; 2012 May; 18(5):594-601. PubMed ID: 22140024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
    Demols A; Maréchal R; Devière J; Van Laethem JL
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1015-29. PubMed ID: 18070701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma.
    Turaga KK; Tsai S; Wiebe LA; Evans DB; Gamblin TC
    Ann Surg Oncol; 2013 Apr; 20(4):1230-9. PubMed ID: 23064778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangiocarcinoma: State of the Art.
    Moazzami B; Majidzadeh-A K; Dooghaie-Moghadam A; Eslami P; Razavi-Khorasani N; Iravani S; Khoshdel A; Shahi F; Dashti H; Mehrvar A; Nassiri Toosi M
    J Gastrointest Cancer; 2020 Sep; 51(3):774-781. PubMed ID: 32157571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation for hilar cholangiocarcinoma.
    Thelen A; Neuhaus P
    J Hepatobiliary Pancreat Surg; 2007; 14(5):469-75. PubMed ID: 17909715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achievable outcomes in the management of proximal cholangiocarcinoma: an update prepared using "evidence-based practice" techniques.
    Killeen RP; Harte S; Maguire D; Malone DE
    Abdom Imaging; 2008; 33(1):54-7. PubMed ID: 17874306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinoma.
    Mosconi S; Beretta GD; Labianca R; Zampino MG; Gatta G; Heinemann V
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):259-70. PubMed ID: 18977670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of Transplant-fallout Patients With Unresectable Cholangiocarcinoma.
    Sio TT; Martenson JA; Haddock MG; Novotny PJ; Gores GJ; Alberts SR; Miller RC; Heimbach JK; Rosen CB
    Am J Clin Oncol; 2016 Jun; 39(3):271-5. PubMed ID: 24921218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholangiocarcinoma: Current Knowledge and New Developments.
    Blechacz B
    Gut Liver; 2017 Jan; 11(1):13-26. PubMed ID: 27928095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
    Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
    Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma of the extrahepatic biliary tree: analysis of 15 cases.
    Mena FJ; Velicia R; Valbuena MC; González JM; Caro-Patón A; Pérez-Miranda M; Bellido J
    Rev Esp Enferm Dig; 1999 Apr; 91(4):297-304. PubMed ID: 10447345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results.
    Seehofer D; Thelen A; Neumann UP; Veltzke-Schlieker W; Denecke T; Kamphues C; Pratschke J; Jonas S; Neuhaus P
    Liver Transpl; 2009 Nov; 15(11):1499-507. PubMed ID: 19877250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of neoadjuvant chemoradiation therapy for clinical Stage II cholangiocarcinoma as a preoperative diagnosis].
    Nakagawa K; Katayose Y; Unno M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1945-7. PubMed ID: 23267938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for hilar cholangiocarcinoma: A systematic review.
    Machairas N; Kostakis ID; Tsilimigras DI; Prodromidou A; Moris D
    Transplant Rev (Orlando); 2020 Jan; 34(1):100516. PubMed ID: 31711828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation for cholangiocarcinoma.
    Masuoka HC; Rosen CB
    Clin Liver Dis; 2011 Nov; 15(4):699-715. PubMed ID: 22032524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.